Comparsion between articaine and lignocaine regional anaesthesian in patients undergoing bone marrow biopsy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2006-005195-40-FI

Enrollment

200

Registered

2006-09-25

Start date

2006-11-06

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients suffering from different forms of leukemia MedDRA version: 8.1 Level: LLT Classification code 10024329 Term: Leukemia

Interventions

Trade Name: Ultracain ohne Adrenalin 40 mg/ml Product Name: Ultracain ohne Adrenalin 40 mg/ml Pharmaceutical Form: Injection* INN or Proposed INN: ARTICAINE HYDROCHLORIDE CAS Number: 23964570 Trade N

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: To compare two different local anaesthetic drugs;Secondary Objective: None;Primary end point(s):	—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026